ELOX (Eloxx Pharmaceuticals) Total Assets: $5.27 Mil (As of Dec. 2025)

What is Eloxx Pharmaceuticals Total Assets?

Eloxx Pharmaceuticals ELOX -6.34% 17 Total Assets is $5.27 Mil as of Dec. 2025. GuruFocus rates ELOX with a GF Score™ of 17/100. The stock has 2 warning signs investors should review.

Eloxx Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2025 was $5.27 Mil.

During the past 12 months, Eloxx Pharmaceuticals's average Total Assets Growth Rate was -83.10% per year. During the past 3 years, the average Total Assets Growth Rate was -36.70% per year. During the past 5 years, the average Total Assets Growth Rate was -20.00% per year. During the past 10 years, the average Total Assets Growth Rate was -23.10% per year.

During the past 13 years, Eloxx Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 124.40%. The lowest was -49.30%. And the median was 8.60%.

Total Assets is connected with ROA %. Eloxx Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2025 was -145.40%. Total Assets is also linked to Revenue through Asset Turnover. Eloxx Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

Eloxx Pharmaceuticals (NAS:ELOX) Total Assets Explanation

Total Assets is connected with ROA %.

Eloxx Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %	=	Net Income (Q: Dec. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Dec. 2025 ))	/ count )
	=	-5.995	/	( (2.976	+	5.27)	/ 2 )
	=	-5.995	/	4.123
	=	-145.40 %

Note: The Net Income data used here is one times the annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Eloxx Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2025 is

	Asset Turnover
=	Revenue (Q: Dec. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Dec. 2025 ))	/ count )
=	0	/	( (2.976	+	5.27)	/ 2 )
=	0	/	4.123
=	0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Eloxx Pharmaceuticals Total Assets Related Terms

Eloxx Pharmaceuticals Total Assets Historical Data

* Premium members only.

The historical data trend for Eloxx Pharmaceuticals's Total Assets can be seen below:

Eloxx Pharmaceuticals Total Assets Chart

Eloxx Pharmaceuticals Annual Data

Trend

Jun16

Jun17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Assets

Get a 7-Day Free Trial

45.14

21.12

1.71

2.98

5.27

Eloxx Pharmaceuticals Semi-Annual Data
	Jun06	Jun07	Jun08	Jun09	Jun10	Jun11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24	Dec25
Total Assets	Get a 7-Day Free Trial															45.14	21.12	1.71	2.98	5.27

17GF Score

Eloxx Pharmaceuticals Inc ELOX

Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Eloxx Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Eloxx Pharmaceuticals's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets	=	Total Equity (A: Dec. 2025 )	+	Total Liabilities (A: Dec. 2025 )
	=	-11.907	+	17.177
	=	5.27

Eloxx Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2025 )	+	Total Liabilities (Q: Dec. 2025 )
	=	-11.907	+	17.177
	=	5.27

Frequently Asked Questions Learn more about Total Assets →

What does a Total Assets of $5.27 Mil mean?

Eloxx Pharmaceuticals (ELOX) has a Total Assets of $5.27 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Eloxx Pharmaceuticals and its competitors.

Is Eloxx Pharmaceuticals' Total Assets too high?

Eloxx Pharmaceuticals' current Total Assets is $5.27 Mil. Overall, Eloxx Pharmaceuticals has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.

How does Eloxx Pharmaceuticals' Total Assets compare to ESLA and RNXT?

Eloxx Pharmaceuticals' Total Assets of $5.27 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Assets for a Biotechnology company?

A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Assets mean?

A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Eloxx Pharmaceuticals and its competitors. Eloxx Pharmaceuticals's current Total Assets is $5.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Eloxx Pharmaceuticals stock overvalued right now?

Eloxx Pharmaceuticals (ELOX) has a current Total Assets of $5.27 Mil. The current Total Assets is $5.27 Mil. Eloxx Pharmaceuticals' overall GF Score™ is 17/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Assets calculated?

Total Assets is calculated from a company's financial statements. For Eloxx Pharmaceuticals (ELOX), the current Total Assets is $5.27 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eloxx Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies ESLA RNXT ABVC ACTU GRCE INMB APLM NTRB HYPD MGX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 10 Court Street, P.O. Box 274, Arlington, MA, USA, 02476

Website https://www.eloxxpharma.com

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

17GF Score

Get the complete analysis for ELOX

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.00

Price

View ELOX Analysis

See Total Assets data for all stocks →